Jasper Therapeutics Inc. Made Headway
Mon, May 02, 2022 at 05:35 PM
Jasper Therapeutics Inc. (JSPR:NASDAQ) shot up at $3.77, a gain of 23.6%. On Fri, Apr 29, 2022, JSPR:NASDAQ hit a New 2-Week High of $3.05. The stock got featured on our News Catalysts scanner on Thu, Apr 28, 2022 at 10:15 AM in the 'BIOTECH' category. From Mon, Apr 18, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Thu, Dec 09, 2021 at $10.69 with a volume of 1M+.
About Jasper Therapeutics Inc. (JSPR:NASDAQ)
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy.
Top 10 Gainers:
- Better Therapeutics Inc. (BTTX:NASDAQ), 120.39%
- SoundHound AI Inc. (SOUN:NASDAQ), 68.46%
- Forge Global Holdings Inc. (FRGE:NYSE), 44.34%
- Redbox Entertainment Inc. (RDBX:NASDAQ), 42.64%
- SOS Limited American Depositary Shares (SOS:NYSE), 39.74%
- Blue Apron Holdings, Inc. (APRN:NYSE), 33.77%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 26.5%
- Jasper Therapeutics Inc. (JSPR:NASDAQ), 23.61%
- MICT, Inc. (MICT:NASDAQ), 23.19%
- Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 23.05%